A nationwide study of the blood of more than 28,000 people found that, as of July, approximately 9.3% in the United States had antibodies to the novel coronavirus. Why dialysis patients? They also compared rates from their study with population case counts from Johns Hopkins University. From that, they estimated that only 9.2% of the patients with antibodies had been officially diagnosed by a test with Covid-19. “A surveillance strategy relying on monthly testing of remainder plasma of patients receiving dialysis can produce unbiased estimates of SARS-CoV-2 spread inclusive of hard-to-reach, disadvantaged populations in the USA.

Source: CNN September 25, 2020 22:30 UTC